headlinespreviousopinionsconnectfields
infoquestionsdashboardupdates

Healthcare Organizations Call for FDA Action on Compounding Regulations Amid GLP-1 Shortages

March 23, 2025 - 10:21

Healthcare Organizations Call for FDA Action on Compounding Regulations Amid GLP-1 Shortages

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) have taken a significant step by sending a letter to the U.S. Food and Drug Administration (FDA). This letter, supported by over 20 prominent organizations and providers from various sectors of healthcare, emphasizes the urgent need for the FDA to implement and enforce federal regulations concerning compounding practices.

The call to action comes in the wake of recent shortages of GLP-1 medications, which are crucial for the treatment of obesity and related conditions. These shortages have raised serious concerns about patient access to essential therapies. The coalition argues that without stricter oversight and regulation of compounded medications, patients may face continued disruptions in their treatment options.

Healthcare leaders are advocating for a timely response from the FDA to ensure that patients receive the medications they need without interruption, highlighting the importance of regulatory frameworks in safeguarding public health.


MORE NEWS

Maryland ranked high among states for public health preparedness, but could be doing more

May 8, 2026 - 11:45

Maryland ranked high among states for public health preparedness, but could be doing more

Maryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...

Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk

May 7, 2026 - 18:47

Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk

The arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....

These companies help parents try to pick their babies' traits. Experts are wary

May 7, 2026 - 03:12

These companies help parents try to pick their babies' traits. Experts are wary

A growing number of fertility clinics and private companies are offering prospective parents the ability to screen embryos not just for major chromosomal abnormalities, but for the statistical...

Tensions Rise Over Affordability and Health Care in California Governor's Debate

May 6, 2026 - 07:08

Tensions Rise Over Affordability and Health Care in California Governor's Debate

Candidates in California`s crowded race for governor clashed over key issues of affordability and health care during a heated debate on Tuesday night. As the June 2 primary election approaches, the...

read all news
suggestionsheadlinespreviousopinionsconnect

Copyright © 2026 Bioflox.com

Founded by: Angelo McGillivray

fieldsinfoquestionsdashboardupdates
privacycookie settingsterms of use